The Multiple Myeloma Daily
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Myeloma Paper of the Day, May 21st, suggested by Robert Orlowski / Alaa Shehadeh, Aseel Ishtay, Batia Avni, cancer, Cyrille Cohen, Eran Zimran, Eyal Lebel,
We have facilitated a network of 150 myeloma-specific support groups that hold regular meetings in the U.S. So no matter where you are, we can…
Myeloma Paper of the Day, May 21st, suggested by Robert Orlowski / Alaa Shehadeh, Aseel Ishtay, Batia Avni, cancer, Cyrille Cohen, Eran Zimran, Eyal Lebel,
Myeloma Paper of the Day, May 20th, suggested by Robert Orlowski / BTK inhibitor, BTKi, cancer, Jorge J. Castillo, MD Anderson Cancer Center, Myeloma Paper…
Kimryn Rathmell: If you are considering a career in Cancer Research remember the NCI / cancer, Cancer research, Cancer Research Careers, Cancer Research
Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). Although most patients eventually progress after autoHCT, a small…
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski / cancer, CAR T-cell therapy, FENIX study, idecabtagene vicleucel, MD Anderson Cancer Center,
B-cell maturation antigen (BCMA)-targeting therapeutics have dramatically improved outcomes in relapsed/refractory multiple myeloma (RRMM). However, whether the mechanisms of resistance between these therapies are shared…
B-cell maturation antigen (BCMA)-targeting therapeutics have dramatically improved outcomes in relapsed/refractory multiple myeloma (RRMM). However, whether the mechanisms of resistance between these therapies are shared…
Myeloma Paper of the Day, May 6th, suggested by Robert Orlowski / Alessandro Cellini, Andrea Visentin, Angelo Paolo Dei Tos, Annalisa Martines, cancer,